Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jan 2026 for AKTIS ONCOLOGY, INC..
Filing timeline
BuySaleVida Ventures II, LLC
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
0%
Median T+90
-18.8%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -21.5%Entry US$21.35 · Close 22 Oct 2026 US$16.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Vida Ventures II, LLC: trading record in brief
Vida Ventures II, LLC is a declared insider of Aktis Oncology, Inc., with filings sourced from SEC (Form 4). Altogether 4 filings, all relating to 12 January 2026.
Every open-market trade on record is a purchase: 2 purchases worth €12.9M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The latest filing, published on 12 January 2026, reports a transaction in Aktis Oncology, Inc. The most recent open-market purchase was published on 12 January 2026, 285 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Vida Ventures II, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
134,842 sharesCommon StockSEC:0001193125-26-010617:2
812,455 shares@ US$18.0097.3% of flowCommon StockSEC:0001193125-26-010617:1
Canonical exit: 12 Apr 2026 (T+90)
22,545 shares@ US$18.002.7% of flowCommon StockSEC:0001193125-26-010617:3
Canonical exit: 12 Apr 2026 (T+90)
4,859,370 sharesCommon StockSEC:0001193125-26-010617:0
4 of 4 declarations
